Deletion or inhibition of CPT-1β can lead to the inhibition of fatty acid oxidation, myocardial lipid accumulation, impaired insulin sensitivity, heart regeneration, cardiac hypertrophy, cardiac fibrosis, and cardiac dysfunction in mice [14,19,20,21,22,23]. Here, CPT1B is linked to cardiac hypertrophy.